BACKGROUND AND PURPOSE: Activation of GABAB receptors in the dentate gyrus (DG) enhances granule cell (GC) activity by reducing synaptic inhibition imposed by hilar interneurons. This disinhibitory action facilitates signal transfer from the perforant path to the hippocampus. However, as the two main molecular subtypes, GABA(B(1a,2)) and GABA(B(1b,2)) receptors, prefer axonal terminal and dendritic compartments, respectively, they may modulate the hilar pathways at different synaptic localizations. We examined their relative expression and functions in the DG. EXPERIMENTAL APPROACH: The localization of GABAB subtypes was revealed immunohistochemically using subunit-selective antibodies in GABA(B1a)(-/-) and GABA(B1b)(-/-) mice. Effects of subtype activation by the GABAB receptor agonist, baclofen, were examined on the perforant path-stimulated GC population activities in brain slices. KEY RESULTS: GABA(B(1a,2)) receptors were concentrated in the inner molecular layer, the neuropil of the hilus and hilar neurons at the border zone; while GABA(B(1b,2)) receptors dominated the outer molecular layer and hilar neurons in the deep layer, showing their differential localization on GC dendrite and in the hilus. Baclofen enhanced the GC population spike to a larger extent in the GABA(B1b)(-/-) mice, demonstrating exclusively disinhibitory roles of the GABA(B(1a,2)) receptors. Conversely, in the GABA(B1a)(-/-) mice baclofen not only enhanced but also inhibited the population spike during GABAA blockade, revealing both disinhibitory and inhibitory effects of GABA(B(1b,2)) receptors. CONCLUSIONS AND IMPLICATIONS: The GABA(B(1a,2)) and GABA(B(1b,2)) receptor subtypes differentially modulate GC outputs via selective axonal terminal and dendritic locations in the hilar pathways. The GABA(B(1a,2)) receptors exclusively mediate disinhibition, thereby playing a greater role in gating signal transfer for hippocampal spatial and pattern learning.
BACKGROUND AND PURPOSE: Activation of GABAB receptors in the dentate gyrus (DG) enhances granule cell (GC) activity by reducing synaptic inhibition imposed by hilar interneurons. This disinhibitory action facilitates signal transfer from the perforant path to the hippocampus. However, as the two main molecular subtypes, GABA(B(1a,2)) and GABA(B(1b,2)) receptors, prefer axonal terminal and dendritic compartments, respectively, they may modulate the hilar pathways at different synaptic localizations. We examined their relative expression and functions in the DG. EXPERIMENTAL APPROACH: The localization of GABAB subtypes was revealed immunohistochemically using subunit-selective antibodies in GABA(B1a)(-/-) and GABA(B1b)(-/-) mice. Effects of subtype activation by the GABAB receptor agonist, baclofen, were examined on the perforant path-stimulated GC population activities in brain slices. KEY RESULTS:GABA(B(1a,2)) receptors were concentrated in the inner molecular layer, the neuropil of the hilus and hilar neurons at the border zone; while GABA(B(1b,2)) receptors dominated the outer molecular layer and hilar neurons in the deep layer, showing their differential localization on GC dendrite and in the hilus. Baclofen enhanced the GC population spike to a larger extent in the GABA(B1b)(-/-) mice, demonstrating exclusively disinhibitory roles of the GABA(B(1a,2)) receptors. Conversely, in the GABA(B1a)(-/-) micebaclofen not only enhanced but also inhibited the population spike during GABAA blockade, revealing both disinhibitory and inhibitory effects of GABA(B(1b,2)) receptors. CONCLUSIONS AND IMPLICATIONS: The GABA(B(1a,2)) and GABA(B(1b,2)) receptor subtypes differentially modulate GC outputs via selective axonal terminal and dendritic locations in the hilar pathways. The GABA(B(1a,2)) receptors exclusively mediate disinhibition, thereby playing a greater role in gating signal transfer for hippocampal spatial and pattern learning.
Authors: N G Bowery; B Bettler; W Froestl; J P Gallagher; F Marshall; M Raiteri; T I Bonner; S J Enna Journal: Pharmacol Rev Date: 2002-06 Impact factor: 25.468
Authors: V Schuler; C Lüscher; C Blanchet; N Klix; G Sansig; K Klebs; M Schmutz; J Heid; C Gentry; L Urban; A Fox; W Spooren; A L Jaton; J Vigouret; M Pozza; P H Kelly; J Mosbacher; W Froestl; E Käslin; R Korn; S Bischoff; K Kaupmann; H van der Putten; B Bettler Journal: Neuron Date: 2001-07-19 Impact factor: 17.173
Authors: Martin Gassmann; Hamdy Shaban; Réjan Vigot; Gilles Sansig; Corinne Haller; Samuel Barbieri; Yann Humeau; Valérie Schuler; Matthias Müller; Bernd Kinzel; Klaus Klebs; Markus Schmutz; Wolfgang Froestl; Jakob Heid; Peter H Kelly; Clive Gentry; Anne-Lise Jaton; Herman Van der Putten; Cédric Mombereau; Lucas Lecourtier; Johannes Mosbacher; John F Cryan; Jean-Marc Fritschy; Andreas Lüthi; Klemens Kaupmann; Bernhard Bettler Journal: J Neurosci Date: 2004-07-07 Impact factor: 6.167
Authors: Kate E Chandler; Alessandra P Princivalle; Ruth Fabian-Fine; Norman G Bowery; Dimitri M Kullmann; Matthew C Walker Journal: J Neurosci Date: 2003-12-10 Impact factor: 6.167
Authors: Bridget L Morse; Gurkishan S Chadha; Melanie A Felmlee; Kristin E Follman; Marilyn E Morris Journal: Am J Drug Alcohol Abuse Date: 2017-06-29 Impact factor: 3.829
Authors: Kenneth A Pelkey; Ramesh Chittajallu; Michael T Craig; Ludovic Tricoire; Jason C Wester; Chris J McBain Journal: Physiol Rev Date: 2017-10-01 Impact factor: 37.312
Authors: Jose Carlos Gonzalez; S Alisha Epps; Sean J Markwardt; Jacques I Wadiche; Linda Overstreet-Wadiche Journal: J Neurosci Date: 2018-06-18 Impact factor: 6.167
Authors: Alejandro Martín-Belmonte; Carolina Aguado; Rocío Alfaro-Ruíz; Ana Esther Moreno-Martínez; Luis de la Ossa; José Martínez-Hernández; Alain Buisson; Ryuichi Shigemoto; Yugo Fukazawa; Rafael Luján Journal: Int J Mol Sci Date: 2020-04-02 Impact factor: 5.923
Authors: Stephan W Schwarzacher; Peter Jedlicka; Julia Muellerleile; Matej Vnencak; Angelo Ippolito; Dilja Krueger-Burg; Tassilo Jungenitz Journal: Mol Neurobiol Date: 2021-11-29 Impact factor: 5.590